Article
Breakingviews - Swedish drugmaker finds alluring poison pill
Rating:
0.0
Views:
57
Likes:
1
Library:
1
Sweden's rare disease drug maker is experiencing unfortunate deal side effects. On Wednesday, shares in Swedish Orphan Biovitrum (SOBI) fell 15% after it announced a plan to buy CTI BioPharma , a specialist in rare blood cancers, for $1.7 billion.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value